To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Expedient detection of atrial fibrillation (AF), the prime suspect in cryptogenic cerebrovascular events (CVE), is required to justify rapid initiation of anticoagulant therapy. Admission ECG and 24-hour Holter remain the usual approach in many centers. Subsequent monitoring is then left to the discretion of the treating physician.